The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation

Experimental and Molecular Pathology

Volumn 97, Issue 2, 2014, Pages 305-313

  Peng, Yue ^a   French, Barbara A ^a   Tillman, Brittany ^a   Morgan, Timothy R ^b   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Alcoholic steatohepatitis; Inflammasome; Liver disease development; Mallory Denk bodies (MDBs)

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE CARD DOMAIN CONTAINING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; FORMALDEHYDE; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NEURONAL APOPTOSIS INHIBITORY PROTEIN; PARAFFIN; PROTEIN; STAT3 PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LIVER BIOPSY; MALLORY DENK BODY FORMATION; PROTEIN EXPRESSION; UPREGULATION;

ALCOHOLIC STEATOHEPATITIS; INFLAMMASOME; LIVER DISEASE DEVELOPMENT; MALLORY-DENK BODIES (MDBS);

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; CASE-CONTROL STUDIES; CASPASE 1; CYTOSKELETAL PROTEINS; EIF-2 KINASE; HEPATITIS, ALCOHOLIC; HUMANS; INFLAMMASOMES; INTERFERON-GAMMA; INTERLEUKINS; MALLORY BODIES; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; NOD1 SIGNALING ADAPTOR PROTEIN; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84910127617     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.08.006     Document Type: Article

References (26)

1. Agostini L., Martinon F., et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20(3):319-325.
2. Basaranoglu M., Turhan N., et al. Mallory-Denk bodies in chronic hepatitis. World J. Gastroenterol. 2011, 17(17):2172-2177.
3. Caldwell S., Ikura Y., et al. Hepatocellular ballooning in NASH. J. Hepatol. 2010, 53(4):719-723.
4. Cerretti D.P., Kozlosky C.J., et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992, 256(5053):97-100.
5. Csak T., Ganz M., et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011, 54(1):133-144.
6. French S.W. The Mallory body: structure, composition, and pathogenesis. Hepatology 1981, 1(1):76-83.
7. French S.W. Nature, pathogenesis and significance of the Mallory body. Semin. Liver Dis. 1981, 1(3):217-231.
8. French S.W., Bardag-Gorce F., et al. Mallory-Denk body pathogenesis revisited. World J. Hepatol. 2010, 2(8):295-301.
9. Haybaeck J., Stumptner C., et al. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Lab. Invest. 2012, 92(6):857-867.
10. Kalina U., Kauschat D., et al. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J. Immunol. 2000, 165(3):1307-1313.
11. Kauppinen A., Niskanen H., et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol. Lett. 2012, 147(1-2):29-33.
12. Kavathas P.B., Boeras C.M., et al. Nod1, but not the ASC inflammasome, contributes to induction of IL-1beta secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol. 2013, 6(2):235-243.
13. Lage S.L., Longo C., et al. Emerging concepts about NAIP/NLRC4 inflammasomes. Front. Immunol. 2014, 5:309.
14. Liu H., Li J. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. Exp. Mol. Pathol. 2014, 97(1):81-88.
15. Liu H., Li J., et al. TLR3/4 signaling is mediated via the NFkappaB-CXCR4/7 pathway in human alcoholic hepatitis and non alcoholic steatohepatitis which formed Mallory-Denk bodies. Exp. Mol. Pathol. 2014, 97(2):234-240.
16. Martinon F., Burns K., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10(2):417-426.
17. Miao E.A., Mao D.P., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(7):3076-3080.
18. Petrasek J., Bala S., et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 2012, 122(10):3476-3489.
19. Saxena M., Yeretssian G. NOD-like receptors: master regulators of inflammation and cancer. Front. Immunol. 2014, 5:327.
20. Subramanian N., Natarajan K., et al. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 2013, 153(2):348-361.
21. Szabo G., Csak T. Inflammasomes in liver diseases. J. Hepatol. 2012, 57(3):642-654.
22. Tilg H., Wilmer A., et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992, 103(1):264-274.
23. Travassos L.H., Carneiro L.A., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2010, 11(1):55-62.
24. Vinzing M., Eitel J., et al. NAIP and Ipaf control Legionella pneumophila replication in human cells. J. Immunol. 2008, 180(10):6808-6815.
25. Zatloukal K., French S.W., et al. From Mallory to Mallory-Denk bodies: what, how and why?. Exp. Cell Res. 2007, 313(10):2033-2049.
26. Zhao Y., Yang J., et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011, 477(7366):596-600.